Research

Life Sciences & Biotechnology

Title :

Human monoclonal antibodies against SARS-CoV-2

Area of research :

COVID-19 Research, Life Sciences & Biotechnology

Focus area :

SARS-CoV-2 virus

Principal Investigator :

Dr Anmol Chandele, Group Leader, Emory Vaccine Program-The International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi

Timeline Start Year :

2020

Contact info :

Details

Executive Summary :

This project aims to generate and analyse human monoclonal antibodies from single cell sorted memory B cells derived from COVID-19 recovered individuals in India for their neutralising activity on SARS-CoV-2.

Outcome/Output:

This work showed that nearly half of the COVID-19 recovered individuals developed neutralising antibodies and these individuals can be identified by simple to use SARS-CoV-2 RBD ELISA’s.

Organizations involved